However, the authors could not find an overall correlation between cancer and polymorphisms in the promoter region of the very potent gastric acid secretion inhibitor IL1β, except the finding of a reduced risk of cancer in IL1β-31C carriers in Asian populations. This evidence concerns the gene IL1B and cancer.